Lack of Heterogeneity in Clinical Trials Resulting from Mistrust in U.S. Medical System
For many years, people from racial and ethnic minority groups have been vastly underrepresented in clinical trials. This is despite the fact that they are affected by many health conditions, such as diabetes and hypertension, at higher rates than other groups. According to the Robert A. Winn Diversity in Clinical Trials Award Program, 80% of… Read More »